No Finish Line Means No Limits

We are focused on constant innovation to improve patients’ lives and arming healthcare providers with life-changing solutions in gastroenterology.

Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases and disorders. We are focused on constantly innovating to improve patients’ lives.

We gain a deeper understanding of the GI conditions our products treat by connecting with the patients who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of expertise include overt hepatic encephalopathy, irritable bowel syndrome with diarrhea, irritable bowel syndrome with constipation, chronic idiopathic constipation, opioid-induced constipation, bowel preparation and ulcerative colitis.

We employ dedicated and innovative team members who are driven to problem-solve. We strive to improve upon existing treatments, uncover new breakthroughs, and deliver comprehensive practice support to arm HCPs with life-changing solutions.

The landscape of healthcare will continue to change, and new patients will continue to present with new needs. That’s why there is no finish line for our innovation and no limit to our potential.

A Long History of Discovery

More than three decades of leading GI treatment breakthroughs

Read Our Story

Your Share of Possible

Bausch Health Companies Inc. gives our shareholders an investment in endless possibilities

Stay Up to Date

The Highest Standards

We realize that operating with transparency develops and fosters trust

Visit, Ask, Connect

Have a medical, investor, or media-related question?